GeneDx Holdings Corp. (WGS)
66.65
-1.88
(-2.74%)
USD |
NASDAQ |
Oct 08, 15:06
GeneDx Holdings Max Drawdown (5Y) : 99.85% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.85% |
| August 31, 2026 | 99.85% |
| July 31, 2026 | 99.85% |
| June 30, 2026 | 99.85% |
| May 31, 2026 | 99.85% |
| April 30, 2026 | 99.85% |
| March 31, 2026 | 99.85% |
| February 28, 2026 | 99.85% |
| January 31, 2026 | 99.85% |
| December 31, 2025 | 99.85% |
| November 30, 2025 | 99.85% |
| October 31, 2025 | 99.85% |
| September 30, 2025 | 99.85% |
| August 31, 2025 | 99.85% |
| July 31, 2025 | 99.85% |
| June 30, 2025 | 99.85% |
| May 31, 2025 | 99.85% |
| April 30, 2025 | 99.85% |
| March 31, 2025 | 99.85% |
| February 28, 2025 | 99.85% |
| January 31, 2025 | 99.85% |
| December 31, 2024 | 99.85% |
| November 30, 2024 | 99.85% |
| October 31, 2024 | 99.85% |
| September 30, 2024 | 99.85% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.85% |
| July 31, 2024 | 99.85% |
| June 30, 2024 | 99.85% |
| May 31, 2024 | 99.85% |
| April 30, 2024 | 99.85% |
| March 31, 2024 | 99.85% |
| February 29, 2024 | 99.85% |
| January 31, 2024 | 99.85% |
| December 31, 2023 | 99.85% |
| November 30, 2023 | 99.85% |
| October 31, 2023 | 99.78% |
| September 30, 2023 | 99.60% |
| August 31, 2023 | 99.51% |
| July 31, 2023 | 99.36% |
| June 30, 2023 | 99.35% |
| May 31, 2023 | 99.29% |
| April 30, 2023 | 99.13% |
| March 31, 2023 | 99.13% |
| February 28, 2023 | 99.13% |
| January 31, 2023 | 99.13% |
| December 31, 2022 | 99.13% |
| November 30, 2022 | 98.40% |
| October 31, 2022 | 96.70% |
| September 30, 2022 | 96.70% |
| August 31, 2022 | 96.05% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Twist Bioscience Corp. | 94.48% |
| CS Diagnostics Corp. | 99.99% |
| Aibotics, Inc. | 99.99% |
| Intellia Therapeutics, Inc. | 96.45% |
| 10X Genomics, Inc. | 96.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.33 |
| Beta (5Y) | 1.954 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 127.9% |
| Historical Sharpe Ratio (5Y) | -0.2017 |
| Historical Sortino (5Y) | -0.4924 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.84% |